Abtrace is a UK-based deep tech medical startup created in 2018. With its technology, Abtrace aims to provide advanced digital solutions that allow healthcare professionals not only to react and manage the patient's current diseases, but also to recognize the first clinical signs of new conditions. The company is promoting a paradigm shift from a reactive care provision to a proactive care, from late diagnosis to early detection with integrated, data driven and machine learning based tools validated in health settings in a compliant manner. Abtrace scans the entire patient record to identify the multiple reasons why a patient might require monitoring tests and support clinicians deliver these in a single appointment. The same platform is being used to identify early signals that a patient might be developing a disease like cancer and support the clinician initiate an earlier diagnosis.